Table 3.
Stage 1 | HSC (N = 117) | D&C (N = 59) | P value |
---|---|---|---|
Histologic type | |||
endometrioid adenocarcinoma | 112 (95.7%) | 56 (94.9%) | 0.807* |
non-endometrioid adenocarcinoma | 5 (4.3%) | 3 (5.1%) | |
Tumour differentiation | |||
G1 | 75 (64.1%) | 29 (49.2%) | 0.156* |
G2 | 32 (27.4%) | 22 (37.3%) | |
G3 | 10 (8.5%) | 8 (13.5%) | |
Myometrial invasion | |||
none | 5 (4.3%) | 3 (5.1%) | 0.079* |
less than ½ | 71 (60.7%) | 45 (76.2%) | |
more than ½ | 41 (35.0%) | 11 (18.6%) | |
Peritoneal cytology positive or suspicious negative | 15 (12.8%) 102 (87.2%) | 2 (3.4%) 57 (96.6%) | 0.046* |
Time from diagnosis to operation (days) | 35.6 ± 14.0 | 33.1 ± 12.7 | 0.255** |
chi-square test
independent sample t-test